Search All News
Dr. Raza and Dr. Ali will focus on developing new strategies to target tumor macrophage hybrid cells in order to prevent cancer metastasis and overcome resistance to traditional cancer therapies.
Four teams of researchers at Columbia University have been awarded 2023 Edward P. Evans Center for Myelodysplastic Syndromes (MDS) Pilot Awards and Fellowships
In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
New awards program supports cutting-edge research dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells.
- December 15, 2021
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.